Individualized threshold of the involuntary weight loss in prognostic assessment of cancer.

Hailun XieHeyang ZhangGuotian RuanLishuang WeiYizhong GeShiqi LinMengmeng SongZiwen WangChenan LiuJinyu ShiXiaoyue LiuMing YangXin ZhengYue ChenXiaowei ZhangHan Ping Shi

Published in: Journal of cachexia, sarcopenia and muscle (2023)

An individualized threshold for WL based on baseline BMI can be used for prognostic assessment in cancer patients. WL and BMI should be evaluated simultaneously in treatment decision-making, nutritional intervention, and prognosis discussions of patients with cancer.

Keyphrases

weight loss
decision making
body mass index
randomized controlled trial
bariatric surgery
papillary thyroid
weight gain
roux en y gastric bypass
squamous cell
metabolic syndrome
type diabetes
skeletal muscle
lymph node metastasis